Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences Inc (NQ: ACHV )

4.450 +0.090 (+2.06%)
Streaming Delayed Price Updated: 10:06 AM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,949
Open 4.270
Bid (Size) 4.400 (1)
Ask (Size) 4.480 (1)
Prev. Close 4.360
Today's Range 4.202 - 4.460
52wk Range 2.000 - 10.30
Shares Outstanding 18,040,760
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
+75.89%
+75.89%
1 Month
-4.09%
-4.09%
3 Month
-19.96%
-19.96%
6 Month
-13.26%
-13.26%
1 Year
+22.25%
+22.25%

More News

Read More
Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial
Via Benzinga
Recap: Achieve Life Sciences Q1 Earnings
Via Benzinga
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences's Earnings: A Preview
Via Benzinga
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
From Achieve Life Sciences
Via GlobeNewswire
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week High
Via Investor Brand Network
Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment
Via Benzinga
Top 5 Health Care Stocks That May Collapse
Via Benzinga
Achieve Life Sciences Announces Refresh to Board of Directors
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via GlobeNewswire
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
From Achieve Life Sciences
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
Via Benzinga
Achieve Life Sciences Announces Private Placement of $18.9 Million
From Achieve Life Sciences
Via GlobeNewswire
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
From Achieve Life Sciences
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.